Oliver Wyman Health Innovation Summit 2021

In physics, motion is measured by mass and acceleration. In healthcare, motion is based on how fast we move, how much progress we make, and at what scale. Some opportunities came to fruition through necessity over the last year. Other opportunities — already in motion for years — accelerated and expanded during the pandemic. Since the start of 2020, we’ve gone from piloting new care models, offerings, business models, and industry structures, to making them the way we do business. At this year’s Summit, we’ll dig into what’s moving at high velocity and what’s demonstrating impact with sufficient mass — in hopes of understanding the implications and potential of the opportunities in motion.

What to Expect

Connecting, challenging, and building community

For this year’s virtual Summit, we’re convening as an Oliver Wyman Health Innovation Center community like never before. We’ll start with a one-day kickoff in September packed with inspirational, thought-provoking speakers. We’ll then spend the next seven weeks continuing the conversation, learning from industry innovators and each other. And we’ll conclude with a reflective, action-oriented gathering in November. As a result, we’ll have the opportunity to build from one session to the next, to keep challenging each other as leaders, and to incorporate the power of the Summit into our day-to-day lives.

The Right People, The Right Content

Bernard (Bernie) Banks is a noted expert on the subjects of leadership and organizational change. Currently, he is the Associate Dean for Leadership Development and Inclusion (and a Clinical Professor of Management) at Northwestern University’s Kellogg School of Management. As an Associate Dean, Bernie is accountable for leader development integration across the school’s global portfolio of degree programs. He also leads the institution’s diversity, equity, and inclusion initiatives.

Bernie retired from the US Army with the rank of Brigadier General after having successfully led West Point’s Department of Behavioral Sciences & Leadership for his final military assignment. In addition to having studied leadership extensively, he has led multiple organizations ranging in size from 10 to over 3000 people. In 1995, Bernie was selected from over 40,000 officers to receive the Army’s top award for entry-level managers (General Douglas MacArthur Leadership Award). In 2006, the Apache Helicopter unit he was leading in South Korea was designated as the number one US Army Apache Helicopter unit globally.

Bernie is a broadly educated scholar-practitioner. He attained his bachelor’s degree from West Point and a Ph.D. in social-organizational psychology from Columbia University. Bernie also holds master’s degrees from Northwestern, Columbia, and Harvard Universities. Bernie has published work in a variety of outlets (e.g., Harvard Business Review, Military Psychology, and New York Times). Furthermore, he has worked extensively with organizations across all sectors concerning their leader development efforts (e.g., Morgan Stanley, Procter and Gamble, Mercedes Benz, Microsoft, IBM, 7-Eleven, Goldman Sachs).

An active member of several civic and professional organizations (e.g., The Chicago Club, The Economic Club of Chicago), Bernie is deeply invested in his community.

Dan Barouch received his PhD in immunology from Oxford University and his MD from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, a member of the Ragon Institute of MGH, MIT, and Harvard, and part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery. His laboratory focuses on studying the immunology and virology of HIV-1 infection and developing novel vaccine and eradication strategies. His group has also applied their vaccine expertise to preclinical and clinical studies of other infectious diseases of global significance, including Zika virus, tuberculosis, and most recently SARS-CoV-2. His recent work contributed to the development of the single-shot Johnson & Johnson COVID-19 vaccine, which is now being rolled out in the United States and throughout the world. He was elected to the National Academy of Medicine in 2020.

Nzinga Harrison, a well-respected physician and educator, is the Chief Medical Officer and Co-Founder of Eleanor Health, an innovative company built on equity and justice that develops mental health medical homes for individuals affected by opioid and other substance use disorders. As host of the In Recovery weekly podcast by Lemonada Media, she engages a large audience on topics related to addiction. As Co-Founder and Vice-Chair of the Board of Physicians for Criminal Justice Reform, Inc., she leads advocacy at the intersection of health and criminal justice. She earned her bachelor’s degree in Biology with Spanish and Chemistry minors at Howard University, completed medical school at the University of Pennsylvania School of Medicine and completed General Psychiatry Residency at Emory University. She is Board-Certified in both Adult General Psychiatry and Addiction Medicine and has spent her career treating individuals with Serious Persistent Mental Illness and Addictive Diseases and advocating for stigma reduction, justice and equity in healthcare. Currently, she holds adjunct faculty appointments at the Morehouse School of Medicine Department of Psychiatry and is Campaign Psychiatrist for Let’s Get Mentally Fit, a public education and stigma-reduction campaign.

Mario Schlosser is the CEO and co-founder of Oscar, a leading insurer built to make health care easy. Under his leadership, Oscar develops seamless technology and provides personalized support to help more than 540,000 members navigate their health care. Oscar has been recognized as one of Fast Company’s most innovative companies in health, one of CNBC’s top 50 disruptors, and one of TIME’s most influential in health care.

Previously, he co-founded the largest social gaming company in Latin America, where he led the company’s analytics and game design practices. Prior to that, Schlosser was a Senior Investment Associate at Bridgewater Associates and worked as a consultant for McKinsey & Company in Europe, the U.S. and Brazil.

Schlosser also spent time as a visiting scholar at Stanford University, where he wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed the EigenTrust Algorithm to securely compute trust in randomized networks. In May 2019, Schlosser and his co-authors, Sepandar D. Kamvar (Mosaic Building Group Inc) and Héctor Garcia-Molina (Celo), received the prestigious Seoul Test of Time Award from the International World Wide Web Conference Committee (IW3C2) for this work.

Schlosser holds a degree in computer science with highest distinction from the University of Hannover in Germany and an MBA from Harvard Business School.

Ashley Smith is a Partner in Oliver Wyman’s Health and Life Sciences practice, based in San Francisco. She focuses on advising payers, health systems, pharmaceutical companies and retailers on forming unique partnerships to capture value in the changing healthcare market.

Prior to Oliver Wyman, Ashley was an associate in the Strategy and Corporate Development group at Mercer, the world’s leading provider of HR and related financial services, where she supported global business strategy, new offer development, merger, acquisition, and divestiture activities. In addition, she spent time at Booz & Company and Keefe, Bruyette & Woods.

Ashley received a BS in business administration, BA in economics (honors), and a BA in English literature from the University of California, Berkeley where she was also a member of Cal’s Pac-10 and NCAA-champion women’s rowing team.

Glen Tullman is the Executive Chairman and Chief Executive Officer of Transcarent, the first comprehensive, consumer-directed health and care platform for employees of self-insured employers and their families. Born in Silicon Valley, Transcarent’s platform empowers consumers with the kind of information, guidance and access that leads to better care, better outcomes, and more cost-effective decisions for everyone.
Tullman is the former Executive Chairman, Chief Executive Officer, and Founder of Livongo Health, the first at-scale consumer digital health company to truly empower people with chronic conditions to live better and healthier lives using data science.
In his final year, he led Livongo through the largest consumer digital health Initial Public Offering in history, a secondary offering, a convertible debt offering that raised over $550 million, and the industry’s largest merger to date between Livongo and Teladoc Health, valuing Livongo at $18.5 billion and beginning a new era of consumer centric virtual care.
A visionary leader and entrepreneur, Tullman previously ran two other public companies that changed the way health care is delivered. During his time as Chief Executive Officer of Allscripts, the Company was the leading provider of electronic prescribing, practice management, and electronic health records. Glen led Allscripts IPO and Secondary offerings. Prior to Allscripts, he was Chief Executive Officer of Enterprise Systems, the leading resource management systems for hospitals, which he also took public and then sold to McKesson/HBOC. Before entering healthcare, Tullman served as President and COO of CCC Information Systems, a provider of computerized systems for the property and casualty insurance sector.
Tullman is also one of two Founding Partners at 7wireVentures, one of the highest returning venture capital funds in Illinois. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic-condition epidemic facing our country.
Glen is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until cures are found. A strong proponent of philanthropy, he was honored in 2019 with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. He also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a Board Member and the incoming Chairperson of the American Diabetes Association. Tullman has three amazing children that inspire him every day.

As CEO of Evernorth, Cigna Corporation’s dynamic $100B+ health services portfolio, Tim Wentworth brings together the vast array of Evernorth’s health services capabilities, along with those from partners across the health care system in pharmacy solutions, benefits management, care solutions, and data and analytics. Prior to this role, Tim served as president, Express Scripts and Cigna Services, where he led a broad range of pharmacy services, including benefits management and specialty pharmacy services.

Prior to Cigna’s acquisition of Express Scripts in 2018, Tim served as president and CEO of Express Scripts, where he championed better healthcare by aligning with plan sponsors, taking on tough challenges and delivering patient-centered care. During his earlier tenure at Medco, which combined with Express Scripts in 2012, he led the employer and key accounts organizations. He also served as President and CEO of Accredo, the company’s specialty pharmacy. He previously held leadership positions at Mary Kay Inc. and Pepsi Co.

A leader in his field, Tim serves as a director of the Columbia University Health Policy & Management National Advisory Board; a trustee of Columbia University teachers college; a trustee of the University of Rochester (New York); a member of the American Heart Association CEO Roundtable; a director for Civic Progress (St. Louis); a director of Concordance Academy of Leadership (St. Louis); and a director of the Opera Theatre of Saint Louis. He is also an active signatory to the CEO Action for Diversity & Inclusion pledge.

Tim earned a bachelor’s degree in industrial and labor relations from Cornell University and an associate’s degree in business from Monroe Community College. He received an honorary doctorate degree from the State University of New York.

George Whitesides is the Chairman of the Space Advisory Board for Virgin Galactic, a human spaceflight company founded by Richard Branson. Whitesides was the first CEO of the company, growing the company over a decade from a small team to the global aerospace firm it is today. Under Whitesides’ leadership, the company flew the first human spaceflight from US soil since the retirement of the Space Shuttle, flew the first woman to space on a commercial space vehicle, and took the company public on the NYSE. Prior to Galactic, he worked on President Obama’s transition team, and subsequently served as NASA Chief of Staff for NASA Administrator Charlie Bolden. Whitesides was awarded the Distinguished Service Medal, NASA’s highest honor, upon his departure in 2010.

Whitesides has testified on American space policy before the United States Senate, the United States House of Representatives, and the President’s Commission on Implementation of United States Space Exploration Policy. He serves on a variety of philanthropic councils and boards, including Caltech’s Space Innovation Council, Princeton’s Advisory Council for Mechanical and Aerospace Engineering, and the advisory board for the Alliance for SoCal Innovation. He serves as a mentor for the Brook Owens Fellowship program, for increased representation of female leadership in the aerospace industry, and helped start the BLAST scholarship program to mentor Black aerospace student-leaders, in partnership with UNCF. He did his undergraduate degree in Public and International Affairs at Princeton University, an MPhil in GIS and Remote Sensing at Cambridge University, and a Fulbright Scholarship in Tunisia.

Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system.

Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S.
Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world’s first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle.

Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health.

Julie serves on a number of portfolio company boards, including Akasa, Firefly Health, Ribbon Health and Tomorrow Health.

Our Partners

Our Thinking

The Oliver Wyman Health Innovation Center (OWHIC) was created to develop and promote market-driven solutions to the crisis of high cost and poor quality that afflicts the healthcare systems of the developed world.

Based on the deep healthcare expertise of Oliver Wyman and drawing on a network of innovative leaders across industries, OWHIC identifies and disseminates the ideas and practices that will transform healthcare. Our goal is to create a healthcare system driven by innovation and the needs and desires of consumers, creating value for companies and the public alike.